Catalyst Pharmaceuticals

Catalyst Pharmaceuticals

World Rank (Jan-05-2024)
6,011
Market Cap (Jan-05-2024)
1.824 Billion USD
World Rank (Jul-30-2023)
6,873
Market Cap (Jul-30-2023)
1.501 Billion USD
World Rank (Jan-07-2022)
11,623
Market Cap (Jan-07-2022)
0.676 Billion USD
World Rank (Jan-01-2021)
13,003
Market Cap (Jan-01-2021)
0.346 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
CPRX
Market Cap (Mar-08-2026)
2.96
Employee Count
82
Employee Count as of Date
As on 2022
Headquarters City/State
Florida
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
214 Million USD
Annual Operating Income in USD
101 Million USD
Annual Net Income in USD
83 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
375 Million USD
Total Liabilities in USD
75 Million USD
Total Equity in USD
300 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Biotechnology
Company Website
CATALYST PHARMACEUTICALS
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile

Catalyst Pharmaceuticals is a Biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating neuromuscular and neurological diseases. The headquarters is in USA.

Facts About Company

Catalyst Pharmaceuticals Annual Total Revenue for year ending Dec-2022 was 214 million USD and and Net Income for year ending Dec-2022 was 83 million USD.

Catalyst Pharmaceuticals Annual Total Revenue for year ending Dec-2021 was 140 million USD and and Net Income for year ending Dec-2021 was 39 million USD.

As on 2022, Catalyst Pharmaceuticals has 82 employees.

Founded Year
2002
IPO Year
2006
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share